Search Results - G. Tarantini.
- Showing 1 - 9 results of 9
-
1
-
2
SP09 | LYMPH NODES INVOLVEMENT BY ACUTE MYELOID LEUKEMIA IN MYELODISPLASTIC SYNDROME/MYELOPROLIFERATIVE NEOPLASMS: MORPHOLOGIC DISCORDANCE WITH BONE MARROW DISEASE, CLINICAL AND BI... by V. Carluccio, T.M. Santeramo, G. De Santis, C. Buquicchio, R.M. Miccolis, M. Leo, C.R. Germano, N/A S.Mallano, E. Arcuti, V. Strafella, D. Loconte, G. Tarantini.
Published in Haematologica (2025-09-01)Get full text
Article -
3
PB2132: COPANLISIB PLUS RITUXIMAB-BENDAMUSTINE FOR RELAPSED-REFRACTORY DIFFUSE LARGE B-CELL LYMPHOMA: RECRUITMENT UPDATE ON AN ONGOING PHASE II TRIAL OF THE FONDAZIONE ITALIANA LIN... by M. Novo, A. Castellino, A. Chiappella, G. Ciccone, M. Balzarotti, A. Arcari, E. Scarpa, A. Tucci, N. Di Renzo, G. Tarantini, G. Gini, M. Moretti, D. Mannina, A. Di Rocco, M. Spina, U. Vitolo
Published in HemaSphere (2022-06-01)Get full text
Article -
4
Real-World Efficacy and Safety of Gemtuzumab Ozogamycin (GO) and 3 + 7 regimen in fit newly diagnosed Acute Myeloid Leukemia (AML) patients. A Retrospective multicenter study of “R... by M. Dargenio, C. Buquicchio, D. Pastore, L. Aprile, L. Ciuffreda, G. Greco, M. Delia, V. Federico, MP. Fina, D. Seripa, R. Matera, G. Tarantini, A. Maggi, L. Melillo, V. Pavone, P. Musto, G. Specchia, N. Di Renzo
Published in Leukemia Research Reports (2025-01-01)Get full text
Article -
5
P17: DARATUMUMAB (D) PLUS LENALIDOMIDE (R) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY-RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN M... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore
Published in HemaSphere (2022-04-01)Get full text
Article -
6
P18: DARATUMUMAB (D) PLUS BORTEZOMIB (V) AND DEXAMETHASONE (D) AS SALVAGE THERAPY FOR PATIENTS WITH REFRACTORY/RELAPSED MULTIPLE MYELOMA (RRMM): INITIAL FOLLOW-UP OF AN ITALIAN MUL... by G Mele, N Cascavilla, N Di Renzo, A Guarini, P Mazza, L Melillo, V Pavone, G Tarantini, P Curci, AP Falcone, C Germano, A Mele, G Palazzo, G Palumbo, G Reddiconto, B Rossini, G Specchia, P Musto, D Pastore
Published in HemaSphere (2022-04-01)Get full text
Article -
7
P174 | EFFICACY AND SAFETY OF ISATUXIMAB, CARFILZOMIB AND DEXAME-THASONE (ISAKD) IN MULTIPLE MYELOMA PATIENTS AT FIRST RELAPSE AFTER AUTOLOGOUS STEM CELL TRANSPLANTATION AND LENALI... by N. Sgherza, P. Curci, O. Battisti, C. Conticello, S. Palmieri, D. Derudas, C. Germano, E.A. Martino, G. Mele, R. Della Pepa, F. Fazio, A. Mele, B. Rossini, G. Palazzo, D. Roccotelli, S. Rasola, M.T. Petrucci, D. Pastore, G. Tarantini, F. Pane, M. Gentile, F. Di Raimondo, E. Resta, P. Musto
Published in Haematologica (2025-09-01)Get full text
Article -
8
DP093 | HYPOMETHYLATING AGENTS ALONE OR IN COMBINATION WITH VENETOCLAX IN VERY ELDERLY ACUTE MYELOID LEUKEMIA PATIENTS: IS LESS BETTER THAN MORE? by F. Tarantini, V. Carluccio, M.A. Urbano, C. Pasciolla, C. Contento, L. Aprile, A.M. Carella, E. Vigna, M. Gentile, A. D’ambrosio, V.P. Gagliardi, M. Delia, I. Attolico, P. Carluccio, G. Tarantini, D. Pastore, A. Guarini, N. Di Renzo, A. Maggi, F. Frigeri, G. Specchia, P. Musto, F. Albano
Published in Haematologica (2025-09-01)Get full text
Article -
9
P1084: CHECK-POINT INHIBITORS IN PATIENTS WITH RELAPSE/REFRACTORY HODGKIN’S LYMPHOMA: A RETROSPECTIVE ANALYSYS BY THE RETE EMATOLOGICA PUGLIESE (REP). by F. Gaudio, G. Loseto, V. Bozzoli, P. R. Scalzulli, A. M. Mazzone, L. Tonialini, V. Fesce, G. Quintana, G. De santis, P. Masciopinto, E. Arcuti, F. Clemente, S. Scardino, G. Tarantini, D. Pastore, L. Melillo, V. Pavone, P. Mazza, A. M. Carella, N. Cascavilla, N. Di Renzo, A. Guarini, P. Musto
Published in HemaSphere (2022-06-01)Get full text
Article
